Molecular Determinants of Ethionamide Resistance in Clinical Isolates of <i>Mycobacterium tuberculosis</i>

Molecular Determinants of Ethionamide Resistance in Clinical Isolates of <i>Mycobacterium tuberculosis</i>

Background: Ethionamide and prothionamide are now included in group C of the WHO recommended drugs for the treatment of tuberculosis resistant to rifampicin and multidrug-resistant tuberculosis. The clinical relevance of ethionamide and prothionamide has increased with the wide spread of resistant t...

Full description

Bibliographic Details
Main Authors:	Anastasia Ushtanit, Elena Kulagina, Yulia Mikhailova, Marina Makarova, Svetlana Safonova, Danila Zimenkov
Format:	Article
Language:	English
Published:	MDPI AG 2022-01-01
Series:	Antibiotics
Subjects:	tuberculosis drug resistance ethionamide isoniazid perchlozone
Online Access:	https://www.mdpi.com/2079-6382/11/2/133

Similar Items

Perchlozone Resistance in Clinical Isolates of <i>Mycobacterium tuberculosis</i>
by: Anastasia Ushtanit, et al.
Published: (2023-03-01)

Phenotypic low-level isoniazid resistance as a marker to predict ethionamide resistance in Mycobacterium tuberculosis
by: Salima Qamar, et al.
Published: (2017-01-01)

Genetic Characterization Conferred Co-Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis Isolates from Southern Xinjiang, China
by: Cao B, et al.
Published: (2023-05-01)

EthA/R-Independent Killing of Mycobacterium tuberculosis by Ethionamide
by: Ang, Michelle L. T., et al.
Published: (2017)

Genetic Variation Putatively Associated with <i>Mycobacterium tuberculosis</i> Resistance to Perchlozone, a New Thiosemicarbazone: Clues from Whole Genome Sequencing and Implications for Treatment of Multidrug-Resistant Tuberculosis
by: Igor Mokrousov, et al.
Published: (2020-10-01)

Study of ethA gene sequence in Ethionamide resistant clinical isolates of Mycobacterium tuberculosis
by: Somaye Moazemi, et al.
Published: (2015-01-01)

Ethionamide-induced gynecomastia: A rare case report
by: Sourindra N. Banerjee, et al.
Published: (2017-01-01)

EthA/R-Independent Killing of Mycobacterium tuberculosis by Ethionamide
by: Sylvie Alonso, et al.
Published: (2017-04-01)

Metabolism and Pharmacokinetics of the Anti-Tuberculosis Drug Ethionamide in a Flavin-Containing Monooxygenase Null Mouse
by: Amy L. Palmer, et al.
Published: (2012-10-01)

The Prospective Synergy of Antitubercular Drugs With NAD Biosynthesis Inhibitors
by: Kyle H. Rohde, et al.
Published: (2021-01-01)

Increased Susceptibility of <i>Mycobacterium tuberculosis</i> to Ethionamide by Expressing PPs-Induced Rv0560c
by: Hoonhee Seo, et al.
Published: (2022-10-01)

GenoType MTBDRplus 1.0® para la detección de resistencia cruzada entre isoniacida y etionamida en aislamientos de Mycobacterium tuberculosis multirresistentes
by: Johana Rueda, et al.
Published: (2015-12-01)

How a PCR Sequencing Strategy Can Bring New Data to Improve the Diagnosis of Ethionamide Resistance
by: Thomas Maitre, et al.
Published: (2022-07-01)

Investigation of isoniazid and ethionamide cross-resistance by whole genome sequencing and association with poor treatment outcomes of multidrug-resistant tuberculosis patients in South Africa
by: L Malinga, et al.
Published: (2016-01-01)

Insights into the Mechanism of Ethionamide Resistance in <i>Mycobacterium tuberculosis</i> through an <i>in silico</i> Structural Evaluation of EthA and Mutants Identified in Clinical Isolates
by: Vinicius Carius de Souza, et al.
Published: (2020-05-01)

Genetic Profile of Linezolid-Resistant <i>M. tuberculosis</i> Clinical Strains from Moscow
by: Anastasia Ushtanit, et al.
Published: (2021-10-01)

Optimization of the conventional minimum inhibitory concentration method for drug susceptibility testing of ethionamide
by: Rajagopalan Lakshmi, et al.
Published: (2013-01-01)

Bacterial Genome-Wide Association Identifies Novel Factors That Contribute to Ethionamide and Prothionamide Susceptibility in <named-content content-type="genus-species">Mycobacterium tuberculosis</named-content>
by: Nathan D. Hicks, et al.
Published: (2019-04-01)

Second-line antitubercular therapy with ethionamide and pyrazinamide causing pellagroid dermatitis presenting as diffuse palmoplantar keratoderma
by: Mahendra M. Kura, MD, DNB, et al.
Published: (2021-11-01)

Nonclinical and Clinical Studies of the New Anti-Tuberculosis Drug «Perchlozone®»
by: Yablonskiy P.K., et al.
Published: (2016-02-01)

Spectrophotometric determination of ethionamide in pharmaceuticals using Folin–Ciocalteu reagent and iron(III)-ferricyanide as chromogenic agents
by: Nagib A.S. Qarah, et al.
Published: (2017-09-01)

A modified decision tree approach to improve the prediction and mutation discovery for drug resistance in Mycobacterium tuberculosis
by: Wouter Deelder, et al.
Published: (2022-01-01)

Characterization of resistance profile of Mycobacterium tuberculosis isolates from patients with tuberculosis in Beira, Sofala - Mozambique
by: Evangelina Inácio Namburete, et al.
Published: (2016-11-01)

Molecular Crystal Forms of Antitubercular Ethionamide with Dicarboxylic Acids: Solid-State Properties and a Combined Structural and Spectroscopic Study
by: Simone Bordignon, et al.
Published: (2020-08-01)

Drug Resistance in Mycobacterium Tuberculosis Isolates to Isoniazid and Rifampin
by: M Pourhajibagher, et al.
Published: (2012-05-01)

Isoniazid, The Frontline of Resistance in Mycobacterium tuberculosis
by: James B. Whitney, et al.
Published: (2002-12-01)

Isoniazid resistance among rifampicin-susceptible Mycobacterium tuberculosis isolates from tuberculosis patients
by: Jyoti Arora, et al.
Published: (2016-01-01)

Contribution of putative efflux pump genes to isoniazid resistance in clinical isolates of Mycobacterium tuberculosis
by: Anshika Narang, et al.
Published: (2017-01-01)

Molecular characterization of Mycobacterium tuberculosis strains resistant to isoniazid
by: Salma Smaoui, et al.
Published: (2016-01-01)

Complication of Mycobacterium tuberculosis treatment: Isoniazid-induced pneumonitis
by: Brian Cody Adkinson, et al.
Published: (2020-11-01)

Apoptosis and Phagocytosis Activity of Macrophages Infected by Mycobacterium tuberculosis Resistant and Sensitive Isoniazid Clinical Isolates
by: Farida J. Rachmawaty, et al.
Published: (2006-06-01)

Mutations in rpoB and katG genes in Mycobacterium isolates from the Southeast of Mexico
by: R Zenteno-Cuevas, et al.
Published: (2009-05-01)

Ethionamide Preconditioning Enhances the Proliferation and Migration of Human Wharton’s Jelly-Derived Mesenchymal Stem Cells
by: Na-Hee Lee, et al.
Published: (2020-09-01)

Characterization of ndh gene of isoniazid resistant and susceptible Mycobacterium tuberculosis isolates from Brazil
by: Rosilene Fressatti Cardoso, et al.
Published: (2007-02-01)

<i>Mycobacterium tuberculosis</i> Adaptation in Response to Isoniazid Treatment in a Multi-Stress System That Mimics the Host Environment
by: Manita Yimcharoen, et al.
Published: (2023-05-01)

Genetic characterization of Mycobacterium tuberculosis complex isolates circulating in Abuja, Nigeria
by: Molina-Moya B, et al.
Published: (2018-10-01)

Performance of the Abbott RealTime MTB RIF/INH resistance assay when used to test Mycobacterium tuberculosis specimens from Bangladesh
by: Kostera J, et al.
Published: (2018-05-01)

Mutation EthAW21R confers co-resistance to protionamide and ethionamide in both Mycobacterium bovis BCG and Mycobacterium tuberculosis H37Rv
by: Mugweru J, et al.
Published: (2018-06-01)

ISONIAZID - MONORESISTANT TUBERCULOSIS IN BULGARIA
by: Stanislava Yordanova, et al.
Published: (2020-05-01)

Highly Sensitive Detection of Isoniazid Heteroresistance in Mycobacterium Tuberculosis by Droplet Digital PCR
by: Zheng Y, et al.
Published: (2022-10-01)